A product from the iodination of MONOIODOTYROSINE. In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones (THYROXINE and TRIIODOTHYRONINE). PubChem
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Fluvoxamine | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Fluvoxamine. |
| Citalopram | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Citalopram. |
| Fluoxetine | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Fluoxetine. |
| Duloxetine | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Duloxetine. |
| Trazodone | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Trazodone. |
| Paroxetine | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Paroxetine. |
| Sertraline | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Sertraline. |
| Sibutramine | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Sibutramine. |
| Nefazodone | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Nefazodone. |
| Escitalopram | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Escitalopram. |
| Zimelidine | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Zimelidine. |
| Dapoxetine | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Dapoxetine. |
| Milnacipran | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Milnacipran. |
| Desvenlafaxine | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Desvenlafaxine. |
| Seproxetine | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Seproxetine. |
| Indalpine | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Indalpine. |
| Ritanserin | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Ritanserin. |
| Alaproclate | The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Alaproclate. |
| Digoxin | The serum concentration of Digoxin can be increased when it is combined with 3,5-Diiodotyrosine. |
| Acetyldigitoxin | The serum concentration of Acetyldigitoxin can be increased when it is combined with 3,5-Diiodotyrosine. |
| Deslanoside | The serum concentration of Deslanoside can be increased when it is combined with 3,5-Diiodotyrosine. |
| Ouabain | The serum concentration of Ouabain can be increased when it is combined with 3,5-Diiodotyrosine. |
| Digitoxin | The serum concentration of Digitoxin can be increased when it is combined with 3,5-Diiodotyrosine. |
| Oleandrin | The serum concentration of Oleandrin can be increased when it is combined with 3,5-Diiodotyrosine. |
| Cymarin | The serum concentration of Cymarin can be increased when it is combined with 3,5-Diiodotyrosine. |
| Proscillaridin | The serum concentration of Proscillaridin can be increased when it is combined with 3,5-Diiodotyrosine. |
| Metildigoxin | The serum concentration of Metildigoxin can be increased when it is combined with 3,5-Diiodotyrosine. |
| Lanatoside C | The serum concentration of Lanatoside C can be increased when it is combined with 3,5-Diiodotyrosine. |
| Gitoformate | The serum concentration of Gitoformate can be increased when it is combined with 3,5-Diiodotyrosine. |
| Acetyldigoxin | The serum concentration of Acetyldigoxin can be increased when it is combined with 3,5-Diiodotyrosine. |
| Peruvoside | The serum concentration of Peruvoside can be increased when it is combined with 3,5-Diiodotyrosine. |
| Iodide I-131 | The therapeutic efficacy of Iodide I-131 can be decreased when used in combination with 3,5-Diiodotyrosine. |
| Lepirudin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Lepirudin. |
| Bivalirudin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Bivalirudin. |
| Alteplase | 3,5-Diiodotyrosine may increase the anticoagulant activities of Alteplase. |
| Urokinase | 3,5-Diiodotyrosine may increase the anticoagulant activities of Urokinase. |
| Reteplase | 3,5-Diiodotyrosine may increase the anticoagulant activities of Reteplase. |
| Anistreplase | 3,5-Diiodotyrosine may increase the anticoagulant activities of Anistreplase. |
| Tenecteplase | 3,5-Diiodotyrosine may increase the anticoagulant activities of Tenecteplase. |
| Abciximab | 3,5-Diiodotyrosine may increase the anticoagulant activities of Abciximab. |
| Drotrecogin alfa | 3,5-Diiodotyrosine may increase the anticoagulant activities of Drotrecogin alfa. |
| Streptokinase | 3,5-Diiodotyrosine may increase the anticoagulant activities of Streptokinase. |
| Dicoumarol | 3,5-Diiodotyrosine may increase the anticoagulant activities of Dicoumarol. |
| Argatroban | 3,5-Diiodotyrosine may increase the anticoagulant activities of Argatroban. |
| Ardeparin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Ardeparin. |
| Phenindione | 3,5-Diiodotyrosine may increase the anticoagulant activities of Phenindione. |
| Fondaparinux | 3,5-Diiodotyrosine may increase the anticoagulant activities of Fondaparinux. |
| Warfarin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Warfarin. |
| Pentosan polysulfate | 3,5-Diiodotyrosine may increase the anticoagulant activities of Pentosan polysulfate. |
| Phenprocoumon | 3,5-Diiodotyrosine may increase the anticoagulant activities of Phenprocoumon. |
| Dipyridamole | 3,5-Diiodotyrosine may increase the anticoagulant activities of Dipyridamole. |
| Heparin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Heparin. |
| Enoxaparin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Enoxaparin. |
| Epoprostenol | 3,5-Diiodotyrosine may increase the anticoagulant activities of Epoprostenol. |
| Acenocoumarol | 3,5-Diiodotyrosine may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | 3,5-Diiodotyrosine may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Coumarin. |
| Ximelagatran | 3,5-Diiodotyrosine may increase the anticoagulant activities of Ximelagatran. |
| Desmoteplase | 3,5-Diiodotyrosine may increase the anticoagulant activities of Desmoteplase. |
| Defibrotide | 3,5-Diiodotyrosine may increase the anticoagulant activities of Defibrotide. |
| Ancrod | 3,5-Diiodotyrosine may increase the anticoagulant activities of Ancrod. |
| Beraprost | 3,5-Diiodotyrosine may increase the anticoagulant activities of Beraprost. |
| Prasugrel | 3,5-Diiodotyrosine may increase the anticoagulant activities of Prasugrel. |
| Rivaroxaban | 3,5-Diiodotyrosine may increase the anticoagulant activities of Rivaroxaban. |
| Sulodexide | 3,5-Diiodotyrosine may increase the anticoagulant activities of Sulodexide. |
| Semuloparin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Semuloparin. |
| Idraparinux | 3,5-Diiodotyrosine may increase the anticoagulant activities of Idraparinux. |
| Cangrelor | 3,5-Diiodotyrosine may increase the anticoagulant activities of Cangrelor. |
| Astaxanthin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Astaxanthin. |
| Apixaban | 3,5-Diiodotyrosine may increase the anticoagulant activities of Apixaban. |
| Otamixaban | 3,5-Diiodotyrosine may increase the anticoagulant activities of Otamixaban. |
| Amediplase | 3,5-Diiodotyrosine may increase the anticoagulant activities of Amediplase. |
| Dabigatran etexilate | 3,5-Diiodotyrosine may increase the anticoagulant activities of Dabigatran etexilate. |
| Danaparoid | 3,5-Diiodotyrosine may increase the anticoagulant activities of Danaparoid. |
| Dalteparin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Dalteparin. |
| Tinzaparin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Tinzaparin. |
| (R)-warfarin | 3,5-Diiodotyrosine may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | 3,5-Diiodotyrosine may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Nadroparin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Nadroparin. |
| Triflusal | 3,5-Diiodotyrosine may increase the anticoagulant activities of Triflusal. |
| Ticagrelor | 3,5-Diiodotyrosine may increase the anticoagulant activities of Ticagrelor. |
| Ditazole | 3,5-Diiodotyrosine may increase the anticoagulant activities of Ditazole. |
| Vorapaxar | 3,5-Diiodotyrosine may increase the anticoagulant activities of Vorapaxar. |
| Edoxaban | 3,5-Diiodotyrosine may increase the anticoagulant activities of Edoxaban. |
| Sodium citrate | 3,5-Diiodotyrosine may increase the anticoagulant activities of Sodium citrate. |
| Dextran | 3,5-Diiodotyrosine may increase the anticoagulant activities of Dextran. |
| Bemiparin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Bemiparin. |
| Parnaparin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Parnaparin. |
| Desirudin | 3,5-Diiodotyrosine may increase the anticoagulant activities of Desirudin. |
| Antithrombin Alfa | 3,5-Diiodotyrosine may increase the anticoagulant activities of Antithrombin Alfa. |
| Protein C | 3,5-Diiodotyrosine may increase the anticoagulant activities of Protein C. |
| Antithrombin III human | 3,5-Diiodotyrosine may increase the anticoagulant activities of Antithrombin III human. |
| Letaxaban | 3,5-Diiodotyrosine may increase the anticoagulant activities of Letaxaban. |
| Darexaban | 3,5-Diiodotyrosine may increase the anticoagulant activities of Darexaban. |
| Betrixaban | 3,5-Diiodotyrosine may increase the anticoagulant activities of Betrixaban. |
| Nafamostat | 3,5-Diiodotyrosine may increase the anticoagulant activities of Nafamostat. |
| Monteplase | 3,5-Diiodotyrosine may increase the anticoagulant activities of Monteplase. |
| Gabexate | 3,5-Diiodotyrosine may increase the anticoagulant activities of Gabexate. |
| Fluindione | 3,5-Diiodotyrosine may increase the anticoagulant activities of Fluindione. |
| Protein S human | 3,5-Diiodotyrosine may increase the anticoagulant activities of Protein S human. |